<- Go Home

Covidien plc

As of January 26, 2015, Covidien plc was acquired by Medtronic plc. Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. The company operates through Medical Devices and U.S. Medical Supplies segments. It sells advanced surgical solutions comprising stapling, vessel sealing, fixation (hernia mechanical devices), mesh, hardware and ablation products, and interventional lung and gastrointestinal solutions, as well as general surgical solutions, including surgical instruments, sutures, and electrosurgery products; and peripheral vascular therapies, such as compression, dialysis, venous insufficiency, peripheral stents, directional artherectomy, and other products, as well as neurovascular therapies comprising coils, neurovascular stents, flow diversion products, and access and delivery products to support procedures. The company also offers patient monitoring products, such as sensors, monitors, and temperature management products; airway and ventilation products, including airway, ventilator, and inhalation therapy products, as well as breathing systems; and nursing care products comprising incontinence, wound care, enteral feeding, urology, and suction products. In addition, it sells patient care products, such as operating room supply products and electrodes; original equipment manufacturer products; and SharpSafety products comprising needles, syringes, and sharps disposal products. The company’s products are used primarily by hospitals and ambulatory care centers, as well as alternate site healthcare providers, such as physician offices. It markets its products through direct sales force and third-party distributors. The company was founded in 2007 and is based in Dublin, Ireland.

Market Cap

$48.5B

Volume

3.9M

Cash and Equivalents

$1.8B

EBITDA

$3.1B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$6.4B

Profit Margin

60.42%

52 Week High

$108.57

52 Week Low

$65.97

Dividend

N/A

Price / Book Value

4.67

Price / Earnings

27.36

Price / Tangible Book Value

-29.18

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$2.5B

Return on Equity

17.90%

Return on Assets

7.80

Cash and Short Term Investments

$1.8B

Debt

$5.1B

Equity

$10.4B

Revenue

$10.6B

Unlevered FCF

$2.1B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches